Stress and Eating Behavior Among University Students - an Randomized Controlled Trial (StrEat)
14 maart 2016 bijgewerkt door: Anders M Sjödin, MD, PhD, Professor, University of Copenhagen
StrEat - Stress and Eating Behavior
The high worldwide prevalence of overweight and obesity as well as metabolic and disease consequences, are well-documented. The positive energy balance underlying obesity is attributable to excess energy intake and/or insufficient energy expenditure. However, it seems that the increase in mean body weight can be sufficiently explained by increases in mean energy intake. It has been proposed that this overeating is partly caused by increased availability of highly processed energy dense, high reward foods. Psychosocial stress and sleep insufficiency is pervasive in industrialized societies. A growing body of evidence suggests stress to be involved in obesity, although it is unknown whether stress is a cause or consequence. Stress affecting dietary intake; skewing intake towards greater consumption of highly palatable energy dense foods, also referred to as high reward foods. A causal relationship between stress and reward seeking behavior is supported by findings from animal studies reporting rewarding behavior by consumption of sweet tasting food in response to a stressor.
Our aim is to investigate differences in purchases of particular food-items in free living individuals, during a stressful (upcoming exam) and non-stressful (no upcoming exam) period.
Hypothesis: Participants will purchase more high reward foods during the pre-exam period, compared to the control non-exam period.
Studie Overzicht
Toestand
Onbekend
Conditie
Interventie / Behandeling
Gedetailleerde beschrijving
STUDY METHODS
Study design:
The study is a randomized controlled two-armed cross-over intervention study. The study is carried out in 50 healthy university students, both genders. In random order the participants will be investigated during stressful-period (prior to an exam) and a non-stressful (control period) period. Each participant will take part in all together four visits, two in the stressful period and two visits in the non-stressful period.
The study will take place, at the Department of Nutrition, Exercise and Sports (NEXS), Faculty of Science at the University of Copenhagen, Rolighedsvej 26, 1958 Frederiksberg C. Recruitment will take place at the University of Copenhagen
STATISTICAL ANALYSES Analysis of the primary outcome (food choices) will be based on an ANCOVA-type linear mixed model with the intervention and allocation order as the fixed effect and person as the random effect. Analysis will be performed using the software R, SAS, STATA or SPSS. Analyses, data processing and writing of the article are expected to extend over the study period and a year beyond.
Studietype
Ingrijpend
Inschrijving (Verwacht)
50
Fase
- Niet toepasbaar
Contacten en locaties
In dit gedeelte vindt u de contactgegevens van degenen die het onderzoek uitvoeren en informatie over waar dit onderzoek wordt uitgevoerd.
Studie Locaties
-
-
-
Frederiksberg, Denemarken, 1958
- Werving
- Nutrition, Exercise and Sports
-
Contact:
- Mads F Hjorth, PhD
- Telefoonnummer: 0045 35332489
- E-mail: madsfiil@nexs.ku.dk
-
Contact:
- Julie B Schmidt, PhD
- Telefoonnummer: 0045 35333650
- E-mail: jbs@nexs.ku.dk
-
-
Deelname Criteria
Onderzoekers zoeken naar mensen die aan een bepaalde beschrijving voldoen, de zogenaamde geschiktheidscriteria. Enkele voorbeelden van deze criteria zijn iemands algemene gezondheidstoestand of eerdere behandelingen.
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
- Kind
- Volwassen
- Oudere volwassene
Accepteert gezonde vrijwilligers
Nee
Geslachten die in aanmerking komen voor studie
Allemaal
Beschrijving
Inclusion Criteria:
- Healthy, weight stabile (defined as no weight gain/loss >3 kg during the past three months) students at the University of Copenhagen
- Age > 18 years, men and women
Exclusion Criteria:
- Purposefully seeking to lose or gain weight
- Diabetes.
- Blood donation < 1 week prior to the study and during the study
- Lactation, Pregnancy or planning of pregnancy during the study
- Inability, physically or mentally, to comply with the procedures required by the study- protocol, as evaluated by the investigator
- Participation in other clinical trials during the study
- Diagnosed with stress
- Daily use of medication influencing biomarkers of stress
Studie plan
Dit gedeelte bevat details van het studieplan, inclusief hoe de studie is opgezet en wat de studie meet.
Hoe is de studie opgezet?
Ontwerpdetails
- Primair doel: Fundamentele wetenschap
- Toewijzing: Gerandomiseerd
- Interventioneel model: Crossover-opdracht
- Masker: Enkel
Wapens en interventies
Deelnemersgroep / Arm |
Interventie / Behandeling |
|---|---|
|
Actieve vergelijker: University Exam Period
This visit takes place the week before an exam at the university assuming that this will induce a stress response.
Measurements (see description elsewhere) are being taken within 1-2 weeks prior to an university exam.
|
This visit takes place one week prior to an exam at the university assuming that students will be stressed in this period.
|
|
Placebo-vergelijker: University Non-exam Period
This visit takes place several weeks post and prior to an exam at the university assuming that students will not be stressed in this period.
Measurements (see description elsewhere) are being taken in a control-period without exams (at least 4 weeks after and 4 weeks prior to an exam)
|
This visit takes place several weeks post and prior to an exam at the university assuming that students will not be stressed in this period.
|
Wat meet het onderzoek?
Primaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Differences in purchase of high reward foods from the gift certificates between the exam-period and non-exam period.
Tijdsspanne: The outcome is assessed twice, once in the exam period (one week prior to an exam) and once in the non-exam period (four to five weeks prior and post an exam ) Data are analyzed after last subject last visit (May 2016)
|
The classification will be done blinded for the outcome assessor.
|
The outcome is assessed twice, once in the exam period (one week prior to an exam) and once in the non-exam period (four to five weeks prior and post an exam ) Data are analyzed after last subject last visit (May 2016)
|
Secundaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Differences in Heart Rate Variability (HRV) based on a one minute breathing test between the exam-period and non-exam period.
Tijdsspanne: The outcome is assessed twice, once in the exam period (one week prior to an exam) and once in the non-exam period (four to five weeks prior and post an exam ) Data are analyzed after last subject last visit (May 2016)
|
The classification will be done blinded for the outcome assessor.
|
The outcome is assessed twice, once in the exam period (one week prior to an exam) and once in the non-exam period (four to five weeks prior and post an exam ) Data are analyzed after last subject last visit (May 2016)
|
|
Differences in morning cortisol measured in saliva between the exam-period and non-exam period.
Tijdsspanne: The outcome is assessed twice, once in the exam period (one week prior to an exam) and once in the non-exam period (four to five weeks prior and post an exam ) Data are analyzed after last subject last visit (May 2016)
|
The classification will be done blinded for the outcome assessor.
|
The outcome is assessed twice, once in the exam period (one week prior to an exam) and once in the non-exam period (four to five weeks prior and post an exam ) Data are analyzed after last subject last visit (May 2016)
|
|
Differences in insulin resistance measured by homeostatic model assessment (HOMA-IR) calculated from insulin and glucose measured in plasma between the exam-period and non-exam period.
Tijdsspanne: The outcome is assessed twice, once in the exam period (one week prior to an exam) and once in the non-exam period (four to five weeks prior and post an exam ) Data are analyzed after last subject last visit (May 2016)
|
The analyses will be done blinded for the outcome assessor.
|
The outcome is assessed twice, once in the exam period (one week prior to an exam) and once in the non-exam period (four to five weeks prior and post an exam ) Data are analyzed after last subject last visit (May 2016)
|
|
Differences in Perceived Stress (Perceived Stress Scale, PSS) between the exam-period and non-exam period.
Tijdsspanne: The outcome is assessed twice, once in the exam period (one week prior to an exam) and once in the non-exam period (four to five weeks prior and post an exam ) Data are analyzed after last subject last visit (May 2016)
|
The analyses will be done blinded for the outcome assessor.
|
The outcome is assessed twice, once in the exam period (one week prior to an exam) and once in the non-exam period (four to five weeks prior and post an exam ) Data are analyzed after last subject last visit (May 2016)
|
|
Differences in eating behavior using the "Three factor eating questionnaire" between the exam-period and non-exam period.
Tijdsspanne: The outcome is assessed twice, once in the exam period (one week prior to an exam) and once in the non-exam period (four to five weeks prior and post an exam ) Data are analyzed after last subject last visit (May 2016)
|
The analyses will be done blinded for the outcome assessor.
|
The outcome is assessed twice, once in the exam period (one week prior to an exam) and once in the non-exam period (four to five weeks prior and post an exam ) Data are analyzed after last subject last visit (May 2016)
|
|
Differences in sleep habits using the "Pittsburgh sleep quality index" between the exam-period and non-exam period.
Tijdsspanne: The outcome is assessed twice, once in the exam period (one week prior to an exam) and once in the non-exam period (four to five weeks prior and post an exam ) Data are analyzed after last subject last visit (May 2016)
|
The analyses will be done blinded for the outcome assessor.
|
The outcome is assessed twice, once in the exam period (one week prior to an exam) and once in the non-exam period (four to five weeks prior and post an exam ) Data are analyzed after last subject last visit (May 2016)
|
|
Differences in sleep duration measured by ActiGraph between the exam-period and non-exam period.
Tijdsspanne: The outcome is assessed twice, in the exam period (one week prior to an exam) and in the non-exam period (four to five weeks prior and post an exam ) Data are analyzed after last subject last visit (May 2016)
|
The analyses will be done blinded for the outcome assessor.
|
The outcome is assessed twice, in the exam period (one week prior to an exam) and in the non-exam period (four to five weeks prior and post an exam ) Data are analyzed after last subject last visit (May 2016)
|
|
Differences in activity measured by ActiGraph between the exam-period and non-exam period.
Tijdsspanne: The outcome is assessed twice,in the exam period (one week prior to an exam) and in the non-exam period (four to five weeks prior and post an exam ) Data are analyzed after last subject last visit (May 2016)
|
The analyses will be done blinded for the outcome assessor.
|
The outcome is assessed twice,in the exam period (one week prior to an exam) and in the non-exam period (four to five weeks prior and post an exam ) Data are analyzed after last subject last visit (May 2016)
|
|
Differences in blood pressure between the exam-period and non-exam period.
Tijdsspanne: The outcome is assessed twice, once in the exam period (one week prior to an exam) and once in the non-exam period (four to five weeks prior and post an exam ) Data are analyzed after last subject last visit (May 2016)
|
The analyses will be done blinded for the outcome assessor.
|
The outcome is assessed twice, once in the exam period (one week prior to an exam) and once in the non-exam period (four to five weeks prior and post an exam ) Data are analyzed after last subject last visit (May 2016)
|
|
Differences in Perceived Stress ( questionaire: RESTQ-76 sport) between the exam-period and non-exam period.
Tijdsspanne: The outcome is assessed twice, once in the exam period (one week prior to an exam) and once in the non-exam period (four to five weeks prior and post an exam ) Data are analyzed after last subject last visit (May 2016)
|
The analyses will be done blinded for the outcome assessor.
|
The outcome is assessed twice, once in the exam period (one week prior to an exam) and once in the non-exam period (four to five weeks prior and post an exam ) Data are analyzed after last subject last visit (May 2016)
|
Medewerkers en onderzoekers
Hier vindt u mensen en organisaties die betrokken zijn bij dit onderzoek.
Sponsor
Onderzoekers
- Studie stoel: Anders M Sjödin, PhD, University of Copenhagen, NEXS
- Hoofdonderzoeker: Mads F Hjorth, PhD, University of Copenhagen
- Hoofdonderzoeker: Julie B Schmidt, PhD, University of Copenhagen, NEXS
Studie record data
Deze datums volgen de voortgang van het onderzoeksdossier en de samenvatting van de ingediende resultaten bij ClinicalTrials.gov. Studieverslagen en gerapporteerde resultaten worden beoordeeld door de National Library of Medicine (NLM) om er zeker van te zijn dat ze voldoen aan specifieke kwaliteitscontrolenormen voordat ze op de openbare website worden geplaatst.
Bestudeer belangrijke data
Studie start
1 februari 2016
Primaire voltooiing (Verwacht)
1 augustus 2016
Studie voltooiing (Verwacht)
1 augustus 2016
Studieregistratiedata
Eerst ingediend
4 maart 2016
Eerst ingediend dat voldeed aan de QC-criteria
14 maart 2016
Eerst geplaatst (Schatting)
15 maart 2016
Updates van studierecords
Laatste update geplaatst (Schatting)
15 maart 2016
Laatste update ingediend die voldeed aan QC-criteria
14 maart 2016
Laatst geverifieerd
1 maart 2016
Meer informatie
Termen gerelateerd aan deze studie
Trefwoorden
Andere studie-ID-nummers
- B321
Plan Individuele Deelnemersgegevens (IPD)
Bent u van plan om gegevens van individuele deelnemers (IPD) te delen?
Nee
Informatie over medicijnen en apparaten, studiedocumenten
Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel
Nee
Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct
Nee
product vervaardigd in en geëxporteerd uit de V.S.
Nee
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .